Supporting fundraising for Maverix Oncology

06 Jan 2026 | by Andrii Koniukh

Maverix Oncology - Supporting fundraising - main

BACK TO BLOG

MaveriX Oncology is exploiting new insights into cancer and immune cell metabolism to advance a new generation of Conditionally Activated Small Molecule TherapeuticsTM designed to specifically co-target cancer and the tumor immune microenvironment.

The Goal

The Goal

Approach

Approach

Results

Results

The Goal

To translate complex scientific concepts into compelling, easy-to-understand visuals that could be used both for fundraising and for enhancing the website.

 

Sign up for our newsletter